Pharmacy and medical organizations lauded a new class action lawsuit against CVS Health and Walgreens, alleging the two pharmacy chains colluded with pharmacy benefit managers (PBMs) to drive up the cost of generic drugs.
The Drug Enforcement Administration wants to slash the production of opioid painkillers by 20% in 2018.
FDA approved the first treatment for patients with a certain type of acute myeloid leukemia, as well as 2 new drugs to treat hepatitis C.
Novo Nordisk’s DEVOTE study reveals interesting findings.
FDA approves new diagnostic test for non-small cell lung cancer.
FDA approved the use of a new fluoroquinolone antibiotic to treat ABSSSI.
FDA has approved a supplemental Biologics License Application (sBLA) for Bayer’s myBETAapp and BETACONNECT Navigator for multiple sclerosis (MS) patients
Potential public health consquences prompts FDA to request removal of opioid pain medication.
Adamis’ epinephrine injection promises to be a lower-cost alterative to EpiPen.
The first generic Truvada for treating and preventing HIV will be available, but when?